The present disclosure generally relates to microneedle applicators and methods for applying a microneedle applicator to skin to treat an area of the skin and/or deliver an active agent to the skin.
Transdermal and topical drug delivery can be used for therapeutic treatment, but the number of molecules that can be effectively delivered using these routes can be limited by the barrier properties of skin. The main barrier to the transport of molecules through the skin is the stratum corneum (the outermost layer of the skin).
A number of different skin treatment methods have been proposed in order to increase the permeability or porosity of the outermost skin layers, such as the stratum corneum, thus enhancing drug delivery through or into those layers. The stratum corneum is a complex structure of compact keratinized cell remnants separated by lipid domains. The stratum corneum is formed of keratinocytes, which make up the majority of epidermal cells, that lose their nuclei and become corneocytes. These dead cells comprise the stratum corneum, which has a thickness of only about 10-30 microns and protects the body from invasion by exogenous substances and the outward migration of endogenous fluids and dissolved molecules. Various skin treatment methods include the use of microneedles, laser ablation, RF ablation, heat ablation, sonophoresis, iontophoresis, or a combination thereof.
Microneedle or micro-pin arrays, also sometimes referred to as microstructured transdermal Systems (MTSs), provide intradermal delivery of active agents, which otherwise would not penetrate the stratum corneum. The sharp microneedle tip is designed to be able to penetrate the stratum corneum layer of the skin, but short enough not to puncture nerve endings, thus reducing or eliminating pain upon insertion. However, the penetration of microneedles to precise levels within the skin tissue and with good reproducibility is often a challenging task. Therefore, unlike the application of traditional patch-based delivery systems, some existing MTSs require the assistance of external energy to ensure efficient and reproducible penetration of microneedles into biological tissue at desired depths. This assistance can be achieved by utilizing an applicator device, which can either be used after positioning the microneedle array on the skin surface, or the applicator device can be integrated with an array of microneedles and, upon activation, can deliver the microneedle array into the skin. The microneedles help to create microchannels in the skin, which in some embodiments, can facilitate delivering an active ingredient. In some constructions, an active ingredient can be applied subsequent to perforating the skin with the microneedles. In some constructions, active component(s) may be coated on the microneedle array and delivered directly through the skin when the stratum corneum is punctured by the microneedles.
One advantage of MTS systems over other skin treatment methods is the pain-free mode of delivery. While various designs of microneedle applicators have been shown to produce micro-channels with greater accuracy and reproducibility, there remains a need for microneedle applicators that provide safety assurance and ease-of-use, particularly to an unskilled or naïve user (e.g., a consumer), such as to minimize the damage to a user's skin; to limit the maximum amount of force that can be applied (and depth of penetration that can be achieved) via the microneedle array; and to prevent unintentional application, e.g., due to premature or unintentional exposure of the microneedle array.
The present disclosure is generally directed to microneedle applicators comprising a counter assembly that can count the number of times a microneedle array (or microneedle array holder) has been moved to an extended position. That is, the counter assemblies of applicators of the present disclosure can be used to count the number of times a specific microneedle array has been used, and can indicate the number to a user, signifying to the user when to change the microneedle array. Such a counter assembly can automatically perform the count as the applicator is used, which can enhance user compliance and ensure that only simple user instructions are needed to operate the applicator correctly and safely.
Some embodiments of the present disclosure provide a microneedle applicator that can include a housing having a base and an opening formed in the base, wherein the base of the housing is configured to be positioned on a skin surface; and a microneedle array holder configured to hold a microneedle array. The applicator can further include an actuator movable with respect to the housing between a first position and a second position to cause the microneedle array holder to move, respectively, between (i) a retracted position in which the microneedle array is recessed within the housing such that the microneedle array does not contact the skin surface when the base of the housing is positioned on the skin surface and the microneedle array is coupled to the microneedle array holder, and (ii) an extended position in which at least a portion of the microneedle array is positioned to contact the skin surface when the base of the housing is positioned on the skin surface and the microneedle array is coupled to the microneedle array holder. The applicator can further include a first biasing element configured to bias the actuator in the first position; and a counter assembly configured to count a number of times the microneedle array holder is moved between the retracted position and the extended position.
In addition, in some embodiments, applicators of the present disclosure can provide force dampening when a user attempts to apply a microneedle array onto a substrate that exceeds a threshold (i.e., maximum) application force. Generally, applicators of the present disclosure include a dampening element allows the microneedle array to retract away from the substrate when the threshold application force is met or exceeded. By limiting the amount of force that can be applied via the microneedle array to skin, the applicators can also control the depth of penetration that is achieved with the microneedles.
Furthermore, in some embodiments, applicators of the present disclosure can provide safety and ease-of-use, particularly to an unskilled or naïve user (e.g., a consumer), and can minimize premature or unintentional exposure to, or penetration by, the microneedle array. For example, in some embodiments, the applicator can include a cover that can protect a microneedle array located inside the applicator and can limit premature or unintentional exposure of the microneedle array. Such a cover can also be movable with respect to an actuation axis (e.g., to an “off-axis” position), to provide clearance for loading a microneedle array into the applicator and to prevent unintentional application, e.g., due to premature or unintentional exposure of the microneedle array.
Some embodiments of the present disclosure provide applicators that can include one or more of: (i) a cover positioned to limit exposure to a microneedle array coupled to (or located inside) the applicator while allowing the cover to be (re)movable to an off-axis position (e.g., to facilitate microneedle array loading); (ii) means for limiting the amount of force that can be applied to the skin via the microneedle array, and (iii) a counter mechanism for counting (and optionally displaying or indicating) the number of times a microneedle array coupled to the applicator has been used.
Other features and aspects of the present disclosure will become apparent by consideration of the detailed description and accompanying drawings.
Before any embodiments of the present disclosure are explained in detail, it is to be understood that the invention is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the following drawings. The invention is capable of other embodiments and of being practiced or of being carried out in various ways. Also, it is to be understood that the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of “including,” “comprising,” or “having” and variations thereof herein is meant to encompass the items listed thereafter and equivalents thereof as well as additional items. Unless specified or limited otherwise, the terms “connected,” “supported,” and “coupled” and variations thereof are used broadly and encompass both direct and indirect connections, supports, and couplings. It is to be understood that other embodiments may be utilized, and structural or logical changes may be made without departing from the scope of the present disclosure. Furthermore, terms such as “front,” “rear,” “top,” “bottom,” and the like are only used to describe elements as they relate to one another, but are in no way meant to recite specific orientations of the apparatus, to indicate or imply necessary or required orientations of the apparatus, or to specify how the invention described herein will be used, mounted, displayed, or positioned in use.
While typically unnecessary or even undesirable in the field of pharmaceuticals or transdermal drug delivery, in some fields and applications, it may be possible or even necessary to reuse the same microneedle array. For example, in cosmetic applications, it may be necessary to treat a desired surface area of skin, such as a contoured surface of a face. Some microneedle designs allow for repeat use, particularly, if repeat use will not negatively affect accurate drug dosing, e.g., in applications where the microneedles are used to perforate skin prior to a topical application of a desired substance. However, most microneedles cannot be repeatedly used to puncture or perforate skin indefinitely, and the microneedles will eventually dull. The number of uses may vary depending on the makeup and configuration of the microneedles.
The applicators of the present disclosure generally provide applicators comprising a counter mechanism or assembly that allow the same microneedle array to be reused, while counting the number of uses to adequately notify a user when a maximum number of uses has been met. At that point, the user can exchange the microneedle array for a fresh, unused array. Some embodiments of the present disclosure employ simple, robust, mechanical counter assemblies that allow some of the same components that drive the actuation of the applicator to serve a dual function of also driving the counter mechanism. Such robust applicators can be relatively inexpensive to manufacture and can allow for counters to be employed in the applicators with a minimal number of additional componentry and without requiring on-board electronics. Such features can be particularly advantageous for consumer-based applications.
Some aspects of the present disclosure can provide microneedle applicators that allow the microneedle array, and particularly, a microneedle array holder configured to hold and move the microneedle array, to retract away from a substrate (e.g., a skin surface) to which the microneedle array is being applied by employing a dampening element. Such a dampening element can include a biasing element that biases the microneedle array holder in an extended position, but which allows the microneedle array holder to be moved to a dampened position against the bias of the biasing element when a threshold (i.e., maximum) application force is applied to the microneedle array. Such an application force ultimately will be ‘felt’ by the applicator as a result of the skin pressing back on the microneedle array (e.g., in a direction generally normal to the skin surface and/or normal to a first skin-facing side of the microneedle array or microneedle array holder); however, the source of the force comes from a user pressing (e.g., over-pressing) the microneedle applicator onto the skin.
In addition, some aspects of the present disclosure can provide a microneedle applicator comprising a cover that is movable with respect to an actuation axis to provide clearance for loading a microneedle array onto a microneedle array holder. After the microneedle array has been loaded onto the holder, the cover can be returned to its initial position where it can at least partially house the microneedle array prior to actuation (i.e., delivery of the microneedle array to a desired substrate, e.g., a skin surface). The cover can include a base configured to be positioned on a skin surface and an opening formed in the base through which the microneedle array can pass, e.g., along an “actuation axis” when the applicator is actuated to deliver the microneedle array (i.e., to puncture or perforate skin with the microneedle array). In some embodiments, the actuation axis can be oriented substantially normal to a surface to which the microneedle array is to be applied, and can also be substantially normal to the base of the cover (or a tangent thereof). The cover can also be movable to a position (i.e., an “off-axis position”) where the actuation axis no longer passes through the opening in the cover, and the microneedle array holder is more exposed, e.g., to facilitate loading a microneedle array onto the holder.
Microneedle applicators of the present disclosure are particularly suitable for consumer-based applications where the applicator will be operated primarily by naïve or unskilled users, as opposed to medical practitioners. Such microneedle applicators are intuitively shaped and designed to convey to a user how the applicator should be operated. For example, in some embodiments, the applicator can be elongated along the actuation axis (i.e., the actuation axis can also be, or be parallel to, the longitudinal axis of the applicator), clearly conveying to a user that the applicator is configured to stamp a microneedle array toward the skin surface, as opposed to using the applicator to scrape or drag a microneedle array along the skin surface. Simple stamping or pressing of the microneedle array into a skin surface can be much less invasive and damaging to skin than abrading or otherwise scraping along an outer surface of the skin. The counter assembly also provides an unskilled user with a count of the number of times a microneedle array has been used to avoid unsafe or ineffective microneedle array application, and to signify to a user when to change the microneedle array.
While some existing applicators and microneedle arrays are designed to be left in place on the skin, continuing to puncture the skin and/or deliver an active agent, the applicators of the present disclosure are designed to allow the microneedles to puncture the skin up to a desired force and to a desired depth, but are generally not designed to be left on the skin for an extended treatment period.
Applicators of the present disclosure may be useful when applied to the skin as a “pretreatment” step, that is, when applied to the skin to disrupt the stratum corneum layer of skin and then removed. The disrupted area of skin may then be useful for allowing enhanced delivery of a topical composition (e.g., a solution, a cream, a lotion, a gel, an ointment, or the like) or patch comprising an active agent that is applied to the disrupted area. Applicators of the present disclosure may also be useful when the microneedles are provided with a dried coating comprising an active agent that dissolves from the microneedles after they are inserted into the skin. As a result, applicators of the present disclosure may have utility for enhancing delivery of molecules to the skin, such as in dermatological treatments, vaccine delivery, or in enhancing immune response of vaccine adjuvants. Furthermore, in some embodiments, the active agent may be applied to the skin (e.g., in the form of a solution that is swabbed onto the skin surface, or as a cream, lotion, gel, ointment, or the like, that is rubbed into the skin surface) prior to applying the microneedles of the applicators of the present disclosure.
When a patch is applied to the treated or disrupted site, the patch can be provided in a variety of forms and can include a drug reservoir comprising an active agent for delivery to the treated site. Any transdermal patch suitable for the continuous transdermal delivery of a therapeutically effective amount of an appropriate medicament may be used. Suitable transdermal patches include gelled or liquid reservoirs, such as in U.S. Pat. No. 4,834,979 (Gale), so-called “reservoir” patches; patches containing matrix reservoirs attached to the skin by an adjacent adhesive layer, such as in U.S. Pat. No. 6,004,578 (Lee et al.), so-called “matrix” patches; and patches containing pressure-sensitive adhesive (PSA) reservoirs, such as in U.S. Pat. No. 6,365,178 (Venkateshwaran et al.), U.S. Pat. No. 6,024,976 (Miranda et al.), U.S. Pat. No. 4,751,087 (Wick) and U.S. Pat. No. 6,149,935 (Chiang et al.), so-called “drug-in-adhesive” patches, the disclosures of which are hereby incorporated by reference. In some embodiments, the drug reservoir can be provided in the form of a matrix layer containing drug, the matrix layer being adhered to a skin-contact adhesive of the patch. Such a matrix may be an adhesive layer. Alternatively, the matrix layer may be non-adhesive or weakly adhesive and rely upon the surrounding rim of skin-contact adhesive on an adhesive patch to secure the patch in place and keep the drug reservoir in contact with the skin surface.
In another embodiment, the drug reservoir can be provided in the form of solid particles embedded on the surface or within the skin-contact adhesive of the patch. In particular, these particles may be hydrophilic, so that contact with aqueous fluid exposed at the surface of the treated skin will cause them to dissolve or disintegrate, thus releasing drug into the skin.
In another embodiment, the drug reservoir can be provided within the skin-contact adhesive of the patch. The drug may be mixed with the skin-contact adhesive prior to forming the patch or it may be applied to the skin-contact adhesive of the patch in a separate process step. Examples of suitable methods for applying drug to an adhesive layer may be found in U.S. Patent Application Publication No. 2003/054025 (Cantor et al.) and U.S. Pat. No. 5,688,523 (Garbe et al.), the disclosures of which are hereby incorporated by reference.
The length of time between (i) treatment of the skin with microneedles to increase permeability and (ii) placement of the active agent in contact with the treated skin area may vary. In some embodiments, this length of time can be kept to a minimum in order to avoid any possibility of the skin barrier reforming through a healing process. The minimum length of time can be generally governed by the time it takes to remove the applicators of the present disclosure from the skin and apply the active agent, for example, by swapping on a solution, rubbing in a cream or lotion, remove the liner of a patch and applying its adhesive over the treated site (e.g., if a patch is being employed), etc. This time may be less than about 1 minute, less than about 30 seconds, less than about 10 seconds, or less than about 5 seconds. There is no reason, however, that this time cannot be extended to many minutes or hours if so desired. It is generally known that the length of time that the skin will remain increasingly permeable after treatment depends on the type of treatment and whether the skin is occluded or not after treatment. In some instances, increased permeability can be maintained for up to several days as long as the treated site remains occluded and even in the absence of occlusion the skin may have increased permeability for up to several hours. Thus, if it presented some convenience or clinical benefit, one could treat the site and delay delivery of an active agent/ingredient by wearing some type of dressing over the treated site until such time as one desired to begin delivery of the active agent, at which time the active agent could be applied to the treated skin.
In discussing the applicators of the present disclosure, the term “downward,” and variations thereof, is sometimes used to describe the direction in which microneedles are pressed into skin, and “upward” to describe the opposite direction. However, those of skill in the art will understand that the applicators can be used where the microneedles are pressed into skin at an angle to the direction of the earth's gravity, or even in a direction contrary to that of the earth's gravity, and these terms are only used for simplicity and clarity to describe relative directions.
In some embodiments, the microneedles 108 can be configured to treat skin (i.e., create small holes or perforations or micropores in the skin) and/or deliver an active agent via skin, particularly, mammalian skin, and particularly, transdermally. Various microneedles that can be employed in applicators and methods of the present disclosure are described in greater detail below.
The term “transdermally,” and variations thereof, is generally used to refer to any type of delivery of an active ingredient that crosses any portion of skin. That is, transdermally can generally include systemic delivery (i.e., where the active ingredient is transported across, or substantially through, the dermis such that the active ingredient is delivered into the bloodstream), as well as intradermal delivery (i.e., where the active ingredient is transported partially through the dermis, e.g., across the outer layer (stratum corneum) of the skin, where the active ingredient is delivered into the skin, e.g., for treating psoriasis or for local anesthetic delivery). That is, transdermal delivery as used herein includes delivery of an active ingredient that is transported across at least a portion of skin (but not necessarily all of the layers of skin), rather than merely being topically applied to an outer layer of the skin.
The “microneedle array” 107 can include the microneedles 108 and any supporting structure or substrate used to support the microneedles 108 and/or to couple the microneedle array 107 to other structures or components of the applicator 100, such as the microneedle array holder 106. For example, in some embodiments, the “microneedle array” 107 can include a substrate (or carrier) 109 from which the microneedles 108 protrude, as well as additional layers or carriers. In the embodiment illustrated in
The microneedle array 107 (e.g., the substrate 109 and/or the base 101) can include the first side 116 comprising the microneedles 108 and a second side 118 opposite the first side 116. The first side 116 can include a first major surface (e.g., defined by the substrate 109 in the illustrated embodiment) from which the microneedles 108 protrude. The first side 116 can be oriented toward the base 112 of the housing 102 (i.e., positioned to face the skin surface 50). That is, a microneedle array 107 can be coupled to the microneedle array holder 106 such that the second side 118 faces the microneedle array holder 106, and the first side 116 is oriented toward the base 112 of the housing 102, i.e., positioned to face the skin surface 50, or be “skin-facing.”
The housing 102, the actuator 104, the microneedle array holder 106 and/or the microneedle array 107 (e.g., the substrate 109) can be formed of a variety of materials, including but not limited to, thermoset plastics (e.g., acetal resin available under the trade designation DELRIN® DuPont Corporation, Wilmington, Del.; other suitable thermoset plastics, or combinations thereof), thermoformable plastics (e.g., polyethylene, polypropylene, other suitable thermoformable plastics, or combinations thereof), or metals (e.g., stainless steel, aluminum, other suitable metals, or combinations thereof), or combinations thereof.
In some embodiments, the housing 102 can include a base 112, which can be generally planar and configured to be positioned toward a skin surface 50 (see, e.g.,
In some embodiments, an elastomeric annular cap can be coupled to the base 112 surrounding the opening 115, which can enhance the connection and/or friction between the housing 102 and the skin 50 when the applicator 100 is positioned on the skin 50 for use.
The microneedle array holder 106 can be located within the housing 102 and can be configured to hold a microneedle array 107 and to stamp the microneedles 108 into a substrate of interest (e.g., skin). As shown in
The snap-fit engagement between the microneedle array 107 and the holder 106 of the illustrated embodiment can allow for facile engagement between a microneedle array 107 and the holder 106; however, the above-described types of coupling or engagement are shown by way of example only, and it should be understood that a microneedle array 107 can be coupled (i.e., removably coupled) to the holder 106 by a variety of coupling means, including, but not limited to, press-fit or friction-fit engagement, other types of snap-fit engagement, magnets, hook-and-loop fasteners, adhesives, cohesives, clamps, heat sealing, stitches, staples, screws, nails, rivets, brads, crimps, detents, other suitable coupling means, or combinations thereof.
The ejector (or “ejector assembly”) 117 can include an elongated pin or shaft 135 that can extend generally along (or generally parallel to) a longitudinal axis A and can include a portion that is accessible from the exterior of the housing 102 (see
By way of example only, the ejector 117 can include a biasing element (or a resilient element) 137 configured to bias the ejector pin 135 in its first position, while allowing the ejector pin 135 to be moved against the bias of the biasing element 137 to move the ejector pin 135 to its second position. By way of example only, the ejector biasing element 137 is in the form of a flat spring; however, any suitable biasing element, such as those described below, can be employed. The ejector 117, or a portion thereof (e.g., one or more projections or flanges 139) can be configured to be coupled to the housing 102 so as to fix the ejector 117 with respect to the housing 102 and the longitudinal axis A. By way of example only, in the illustrated embodiment, two (e.g., diametrically-opposed) projections 139 on the ejector 117 are each received within a channel 141 formed in an inner surface 140 of the housing 102 (see
As shown in
The actuator 104 can include a plunger (or shaft, or piston) 130, as well as any other components that are configured to facilitate movement of the plunger 130. For example, as shown, in some embodiments, the actuator 104 can include one or more buttons 132 or other manually engageable portions or elements that are coupled to the plunger 130 but at least partially reside on the exterior of the housing 102 to allow a user to manually manipulate and control the plunger 130 when the applicator 100 is assembled. The buttons 132 are illustrated by way of example as being slide buttons. Two simultaneously-operable slide buttons are shown by way of example only and for facile user manipulation.
As shown, the plunger 130 can include a first end 131 that can be coupled to, or can interact with, the buttons 132 (e.g., via the counter assembly 110 or other intervening elements, if employed), and a second end 133 that is coupled to, or can interact with, the microneedle array holder 106. By way of example only, the second end 133 of the plunger 130 is illustrated as being dimensioned to be received within a recess 134 formed in an upper portion of the holder 106. Particularly, the second end 133 is configured to be coupled inside the recess 134 via a snap-fit-type engagement. This type of engagement is illustrated by way of example only, but it should be understood that any of the coupling means described above (with respect to the coupling between the microneedle array holder 106 and the microneedle array 107) can be employed.
In some embodiments, the actuator 104 can further include at least a portion of the counter assembly 110, if employed, of which a portion can interact with or be coupled to the button(s) 132, and another portion can interact with and/or be coupled to the plunger 130 (e.g., the first end 131 thereof). In the illustrated embodiment, when a user slides the buttons 132 downwardly (e.g., toward a skin surface 50) relative to the housing 102 from an initial position to an actuated position, the buttons 132 can cause at least a portion of the counter assembly 110 to also move downwardly relative to the housing 102, which in turn, can cause the plunger 130 to move from a first position P1 (see
The actuator 104 can move as an ensemble in response to user manipulation. Generally, the above-described elements making up the actuator 104 are coupled together and movable together from the first position P1 to the second position P2. As a result, the collection of components described above will be referred to in the following description as simply the “actuator” 104, and such description will be understood to apply to any of the above-described components of the actuator 104, as well as the collection of such components. While the elements of the actuator 104 are generally fixed with respect to one another for effective energy transfer and movement, it should be understood that, in some embodiments, there may be some give or play between elements of the actuator 104.
The first biasing element 111 can be configured to bias the actuator 104 in the first position P1, such that a user can move the actuator 104 to the second position P2 against the bias of the first biasing element 111, and the first biasing element 111 can return, or assist in returning, the actuator 104 to the first position P1.
The actuator 104 can be movable with respect to the housing 102 (e.g., against the bias of the first biasing element 111) between the first position P1 and the second position P2 to cause the microneedle array holder 106 to move, respectively, between
The first, retracted position H1 and the second, extended position H2 can be spaced a distance from one another along an actuation axis A′, such that the microneedle array holder 106 is movable along the actuation axis A′, e.g., relative to the housing 102, between the first, retracted position H1 and the second, extended position H2. In some embodiments, as shown, the actuation axis A′ can be aligned along the longitudinal axis A of the applicator 100 (or of the housing 102), such that the holder 106 is movable along the direction in which the applicator 100 (or the housing 102) is elongated. Such embodiments can provide an intuitive and user-friendly design. In some embodiments, the actuation axis A′ may not be exactly aligned along the longitudinal axis A, but the actuation axis A′ can be substantially parallel to the longitudinal axis A. However, the actuation axis A′ need not be aligned along or substantially parallel to the longitudinal axis A.
The actuation axis A′ can generally be oriented substantially normal with respect to the skin surface 50 (and the first side 121 of the holder 106, as well as the first side 116 of the microneedle array 107 when coupled to the holder 106), but this need not be the case. Rather, in some embodiments, the actuation axis A′ can be arcuate or define otherwise nonlinear path(s), etc. The actuation axis A′ simply refers to movement between the first, retracted position H1 and the second, extended position H2.
When the microneedle array holder 106 is in the first, retracted position H1, the holder 106 can be recessed within the housing 102, such that the holder 106 (and the microneedle array 107, when coupled to the holder 106) does not extend beyond the base 112 of the housing 102. That is, when the microneedle array holder 106 is in the first, retracted position H1 and a microneedle array 107 is coupled to the holder 106, the microneedle array 107 can also be in a first, retracted position M1 (see, e.g.,
When the microneedle array holder 106 is in the second, extended position H2 and a microneedle array 107 is coupled to the holder 106, the microneedle array 107 can also be in a second, extended position M2 (see, e.g.,
When the microneedle array holder 106 and the microneedle array 107 are in their respective second positions H2 and M2, at least a portion of the microneedle array 107 (and, potentially, a portion of the microneedle array holder 106) can extend beyond the base 112 of the housing 102. However, this need not be the case, and in some embodiments, it can be preferred for this not to be the case. Rather, in some embodiments, the microneedles 108 can be positioned close enough to the base 112 of the housing 102 (while still being recessed within the housing 102 and without extending beyond the base 112), such that when the base 112 is pressed onto the skin surface 50, the skin 50 is caused to deform or dome up through the opening 115 and into the cavity 114 to a position where the skin 50 is contacted by the microneedles 108. This configuration can be preferred, e.g., in the case of an unskilled user, where it is desirable for the microneedles 108 never to extend beyond the base 112 of the housing 102 in such a way that the unskilled user could potentially use the applicator 100 to scrape the microneedles 108 along the skin surface 50.
The second, extended position H2 can also be used to load a microneedle array 107 onto the holder 106, e.g., by picking up a microneedle array 107 from a loading tray 129, as shown in
However, in some embodiments, such as in embodiments in which it is generally preferred that the microneedles 108 not extend beyond the base 112 of the housing 102, at least a portion of the housing 102 can be movable relative to the remainder of the housing 102 and/or removable from the remainder of the housing 102 in order to expose the microneedle array holder 106. Such a movable and/or removable portion of the housing 102 can allow the microneedle array holder 106 to easily extend beyond a portion of the housing 102, e.g., to load a microneedle array 107. The portion of the housing 102 that can be movable and/or removable can then be replaced, or returned to its original position, after the microneedle array 107 has been loaded.
That is, as shown in
The cover 122 can define the base 112 and the opening 115, can be configured to be positioned on the skin surface 50, and can be configured to be easily grasped and manipulated (e.g., by hand). The cover 122 can be movable, relative to the housing 102 (and the microneedle array holder 106, as well as the other components, including the actuator 104 and the counter assembly 110) between
The term “off-axis” generally refers to a position in which the axis of interest (e.g., the longitudinal axis A and/or the actuation axis A′) does not pass through opening 115, such that when the microneedle array holder 106 is moved between the retracted position H1 and the extended position H2, there is no interaction with the cover 122. Said another way, the microneedle array holder 106 (and the microneedle array 107 when coupled to the holder 106) does not enter into, or is not located in, the portion of the cavity 114 defined by the cover 122 when the cover 122 is in the “off-axis” second position C2.
In some embodiments, as shown in the illustrated embodiment, the cover 122 can be further movable between the first position C1, the second position C2, and a third position C3 (see
As shown, in some embodiments, the cover 122 can include one or more indicators 164 that can include directional cues or instructions to clearly indicate to a user (i.e., an unskilled user) how to move the cover 122. By way of example only, in the illustrated embodiment, the cover 122 includes a directional arrow pointing downwardly to indicate to a user that the cover 122 can be slid downwardly e.g., to the third position C3. Once the cover 122 is in the third position C3, another indicator or directional cue can be exposed to indicate how to move the cover 122 to the second position C2, or the cover 122 can be configured to be obviously movable (e.g., slidable and/or pivotable) at this point, so that a user will readily discern how the cover 122 can be moved to an “off-axis” position to expose the microneedle array holder 106.
As mentioned above, in some embodiments, the cover 122 can be removable from the housing 102; however, in some embodiments, the cover 122 can remain coupled to the housing 102 when the cover 122 is in the first position C1, the second position C2, and the third position C3. In embodiments in which the cover 122 is removable from the housing 102, the cover 122 can be in the “off-axis” second position C2 when the cover 122 is removed or decoupled from the housing 102.
In some embodiments, the cover 122 and the housing 102 can each be formed of more than one part or portion. For example, as shown in
As shown in
A first recess 144a formed in the outer surface 145 of the housing 102 can be elongated and dimensioned to match the shape of the first projection 142 on the cover 122, which is also elongated in shape, such that when the first projection 142 is received in the first recess 144a, the first projection 142 is seated in the first recess 144a, and the cover 122 is not able to be moved (e.g., rotated) to the “off-axis” second position C2. The second recess 144b can be round and/or dimensioned to allow the first projection 142 to be rotated therein about a rotational axis R (see
As mentioned above, the second recess 144b can allow for rotation of the first projection 142 therein, which can also allow for rotation of the cover 122 relative to the housing 102, such that when the first projection 142 is located in the second recess 144b, the cover 122 can swivel or pivot relative to the housing 102, i.e., to be moved to the second position C2. In the illustrated embodiment, by way of example only, the cover 122 can be moved to one of two second positions C2, i.e., the cover 122 can be moved to either side relative to the housing 102 in order to move to the second position C2. However, in some embodiments, only one second position C2 is available to the cover 122, or the cover 122 is moved to the second position C2 by being at least partially decoupled from the housing 102.
The engagement features on the housing 102 can further include an arcuate slot 148 that can be connected to the first slot 143 and/or the second recess 144b by a second slot 150. The arcuate slot 148 is positioned symmetrically about the first slot 143 and the recesses 144, which allows the cover 122 to be moved to either side of the housing 102 to move to a second position C2. The arcuate slot 148 and the second slot 150 can be dimensioned to receive a second projection 152 on the cover 122 that is spaced a distance (e.g., a longitudinal distance) from the first projection 142. By way of example only, the first projection 142 is larger than the second projection 152, and the second projection round in cross-section and is domed. The first projection 142 and the second projection 152 can be located relative to one another such that when the first projection 142 is positioned in the first recess 144a, the second projection 152 is located in the second recess 144b. As the cover 122 is slid downwardly relative to the housing 102, the first projection 142 is moved into the second recess 144b, and the second projection 152 is moved through the second slot 150, into the arcuate slot 148. The first projection 142 can then be rotated in the second recess 144b, and the second projection 152 can be moved in (e.g., slid along) the arcuate slot 148 to either side, thus, causing the cover 122 to move to one of two second positions C2.
In some embodiments, as shown, the engagement features in the outer surface 145 of the housing 102 can further include one or more third recesses 154, which can each be spaced a distance from an end of the arcuate slot 148 and can define detent positions, or stops, for the second projection 152. Two third recesses 154 are shown by way of example only, each third recess 154 being spaced a short distance from an end of the arcuate slot 148. The third recess(es) 154 can allow the cover 122 to be stopped or held in either of the two second positions C2. That is, the second projection 152, along with the third recess(es) 154, can be used to create or define detents or stops that correspond to discrete second positions C2 for the cover 122.
It should be understood that the above-described specific arrangement of engagement features between the housing 102 and the cover 122 is only one possible embodiment of engagement between the cover 122 and the housing 102 that allows for movement (and even discrete positions) between the cover 122 and the housing 102. In addition, the illustrated embodiment allows for decoupling of the cover 122 and the housing 102, because the engagement features on the cover 122 (e.g. the first projection 142 and/or the second projection 152) can be configured to engage the engagement features on the housing 102 (e.g., the first and second recesses 144a, 144b and the third recess 154) in a snap-fit-type engagement, e.g., by providing some flex in arms 146 of the cover 122. Other removable coupling means, such as those described above can also be employed to allow the cover 122 and the housing 102 to be decoupled from one another (and recoupled back together when desired).
The above description and accompanying illustrations describe and illustrate the engagement features on the cover 122 as being the “projections” and engagement features on the housing 102 as being the “recesses.” However, it should be understood that this need not be the case, and that the above relative coupling and movement between the cover 122 and the housing 102 can also be achieved with projections provided on the housing 102 and recesses provided on the cover 122. Alternatively, a combination of projections and recesses on each of the cover 122 and the housing 102 can be employed.
With reference to
As further shown in
As shown in
As further shown in
Some embodiments of the present disclosure provide a kit comprising an applicator of the present disclosure and the loading tray 129 comprising one or more microneedle arrays 107. As shown in
As shown in
After the microneedle array 107 has been loaded onto the holder 106, and the holder 106 has been moved to its retracted position H1, the cover 122 can be moved from its second position C2 back to the third position C3, as shown in
The above process describes loading a microneedle array 107 into the illustrated embodiment of the applicator 100; however, it should be understood that a very similar process can be employed, with appropriate modifications, to load a microneedle array 107 into any applicator of the present disclosure. For example, in embodiments in which the second position C2 of the cover 122 is simply a position in which the cover 122 is decoupled from the housing 102 (see
As described above and illustrated in
As shown in
In some embodiments, the holder 106 does not extend beyond the base 162 of the housing 102 when in its retracted position H1. In such embodiments, the first side 121 of the holder 106 can be recessed with respect to the base 162 of the housing 102 when the holder 106 is in the retracted position H1, or the first side 121 can be coplanar or flush with the base 162 of the housing 102. As a result, in some embodiments, the housing 102 can be configured to contain or “house” the microneedle array holder 106 at least when the holder 106 is in the retracted position H1. In some embodiments, safety can be enhanced by having the holder 106 be sufficiently recessed with respect to the base 162 of the housing 102 when in the retracted position H1, such that after a microneedle array 107 has been picked up, the microneedle array 107 is also recessed with respect to the base 162. Such a configuration can minimize the likelihood that a user would prematurely or undesirably come into contact with the microneedles 108.
As mentioned above, the cover 122 can be removable from the housing 102, and as such, when the cover 122 is described as being “movable relative to” or “movable with respect to” the housing 102 (or the microneedle array holder 106), it should be understood that this can include being removable from the housing 102 in such a way that the cover 122 can be moved from the “on-axis” first position C1 to an “off-axis” second position C2. Furthermore, even in embodiments such as the illustrated embodiment in which the cover 122 is movable relative to the housing 102 (e.g., between the first, second and third positions C1, C2 and C3) while remaining coupled to the housing 102, the cover 122 can also be removable from the housing 102 when the cover 122 is in any of its positions, including the first position C1, the second position C2, and the third position C3.
One advantage of employing a cover 122 that is movable with respect to, or removable from, the housing 102 is that the holder 106 can be exposed to pick up a microneedle array 107 without requiring a user to ever come into contact with the microneedle side of the microneedle array 107. The configuration of the tray 129 and the placement of the microneedle array 107 in a well 156 of the tray 129 (i.e., with the first side 116 of the array 107 facing into the well 156) can also inhibit a user from prematurely or unintentionally coming into contact with the microneedles 108. In addition, after the microneedle array 107 has been picked up by the holder 106, the cover 122 can be moved to the first position C1 wherein the microneedle array 107 is located within (e.g., entirely within) the cavity 114 (e.g., that is at least partially defined by the cover 122) and is recessed with respect to the base 112, such that the microneedles 108 are not exposed for undesirable or premature puncturing of skin. As such, the (re)movable cover 122 can provide a safety feature to the applicator 100.
As described above, in some embodiments, the cover 122 can be rotatably or pivotally movable with respect to the housing 102, e.g., about the rotational axis R. In addition, the cover 122 can be slidably movable with respect to the housing 102, e.g., as shown in the illustrated embodiment when the cover 122 is moved between the first position C1 and the third position C3. As a result, in the illustrated embodiment, the applicator 100 employs rotational (or pivotal) movement and sliding movement between the cover 122 and the housing 102 when the cover 122 is moved between the first position C1 and the second position C2. However, it should be understood that in some embodiments, the cover 122 can be slidable with respect to the housing 102 even in moving between the second position C2 and the third position C3 (or between the second position C2 and the first position C1), and that the slide-and-swivel cover 122 of the illustrated embodiment is shown by way of example only. In some embodiments, a combination of sliding, pivoting and/or other actions can be used to move the cover 122 with respect to the housing 102 between the various positions.
Furthermore, in the illustrated embodiment, the cover 122 is movable between three positions—the first position C1, the second position C2 and the third position C3; however, it should be understood that, in general, the cover 122 is movable between the first position C1 and an “off-axis” second position C2, and the intermediate third position C3 is shown by way of example only. In some embodiments, a plurality of intermediate “third” positions C3 can be employed.
After the microneedle array 107 has been used (e.g., to its maximum number of applications), the ejector pin 135 can be moved from its first position to its second position, against the bias of the biasing element 137, until the second end 138 of the ejector pin 135 presses against the second side 118 of the microneedle array 107 with sufficient force to decouple the microneedle array 107 and the holder 106 (e.g., to disengage the projections 125 on the microneedle array 107 from the apertures 123 on the holder 106 and to disengage the projections 167 from the base 101 of the microneedle array 107). The cover 122 can be moved to the second position C2 to facilitate microneedle array loading as well as ejection.
As mentioned above, in some embodiments, the applicator 100 can include a counter assembly 110 that can be configured to count the number of times the microneedle array 107 is applied to skin, and particularly, is configured to count the number of times the microneedle array holder 106 is moved between the retracted position H1 and the extended position H2. The counter assembly 110 can include a display 168 (see, e.g.,
As shown in
The counter assembly 110 can be employed in embodiments in which it is acceptable for a microneedle array 107 to be applied to the skin surface 50 more than once before being discarded, up to a maximum number of applications. In some embodiments, the applicator 100 can include a locking feature, such that the applicator 100 is inhibited from being used after the maximum number of applications has been reached, e.g., until the microneedle array 107 is discarded (e.g., via the ejector 117) and replaced by a new microneedle array 107. Furthermore, in some embodiments, the counter assembly 110 can be configured to stop at the maximum number of applications until it is triggered to begin recounting by replacing the microneedle array 107.
As shown in
In some embodiments, it may be preferable that loading the microneedle array 107 does not increment the count, and that the count is not incremented until the microneedle array 107 is actually used after loading. In such embodiments, the first counter display position can display a blank or some other symbol representing that the microneedle array holder 106 is empty, and can increment to a “0” after loading. Then, if the microneedle array holder 106 is moved to its extended position H2 with the microneedle array 107 coupled to the holder 106, that movement will be counted, and the counter display 168 will increment to a “1.”
Various counter mechanisms can be employed to achieve this count of the number of uses or applications of the microneedle array 107. One example of a counter assembly that can be employed in applicators of the present disclosure is illustrated in
The applicator 100 can be configured for safe use, especially by an unskilled user. For example, the movable cover 122 can be employed to enhance the safety of the applicator 100. In some embodiments, the safety of the applicator 100 can be enhanced by limiting the amount of force a user can apply to the skin 50 with the microneedles 108. That is, some embodiments of the applicator 100 can include force dampening configured to limit the threshold application force that can be applied to skin 50 with the applicator 100, and particularly, with the microneedles 108. That is, in some embodiments, the applicator 100 can include a force-dampening mechanism, such that when a user continues to press the applicator 100 (and the microneedles 108) into the skin 50, the applicator 100 is configured to inhibit any force beyond a certain threshold from actually being transferred to the skin 50. One example of a force-dampening mechanism that can be employed is illustrated in
As shown in
While the dampened position H3, M3 is illustrated as one discrete position for simplicity, it should be understood that the “dampened position” H3, M3 can refer to any position to which the microneedle array holder 106 (and/or the microneedle array 107) is moved when a threshold application force is achieved that is sufficient to overcome the bias of the second biasing element 113, and can be any of a variety of positions that are located intermediately between the retracted position H1, M1 and the extended position Hz, M2.
A “threshold application force” generally refers to the force required to move the microneedle array holder 106 from its extended position H2, e.g., to the dampened position H3. As a result, the second biasing element 113 can be selected to set the desired threshold application force for the applicator 100. In general, the threshold application force is directed substantially perpendicularly with respect to (or in a direction oriented substantially perpendicularly with respect to) the microneedle array 107 (or the microneedle array holder 106), or substantially normal to the skin surface 50. Particularly, this force is applied by the skin 50 onto the first side 116 of the microneedle array 107 (or the first side 121 of the microneedle array holder 106) as a result of the applicator 100 and the microneedle array 107 being pressed on the skin 50.
The phrase “directed substantially perpendicularly with respect to the microneedle array (or holder)” or “in a direction oriented substantially perpendicularly with respect to the microneedle array (or holder),” or variations thereof, generally refers to a motion that is directed generally perpendicularly or normal to a base or major plane of the microneedle array 107 (or the microneedle array holder 106), e.g., normal to a base of the microneedle array 107 (or the microneedle array holder 106). For example, in some embodiments, a direction that is “perpendicular with respect to the microneedle array (or holder)” can be substantially perpendicular to the first side 116 of the microneedle array 107 (or to the first side 121 of the holder 106), and/or to the skin surface 50 to which the microneedle array 107 is being applied. In some embodiments, the microneedle array 107 (and/or the holder 106) can include an arcuate first side 116, or an outer surface that has some curvature or undulations. In such embodiments, a direction that is “perpendicular with respect to the microneedle array (or holder)” would generally refer to a direction that is normal to an outer surface of the microneedle array 107, e.g., normal to a tangent of such an arcuate surface.
As shown in
As shown, when the microneedle array holder 106 is in the dampened position H3, the microneedle array holder 106 (and optionally, the microneedle array 107) is located within the cavity 114 of the housing 102 (which can include any portion of the cavity 114 formed by the cover 122, if the movable cover 122 is employed), e.g., such that the microneedle array holder 106 is recessed within the housing 102 and spaced a distance from the base 112 of the housing 102.
As further shown in
In embodiments in which the microneedle array 107 or microneedle array holder 106 are located at least partially beyond the base 112 of the housing 102 when the microneedle array holder 106 is in the extended position H2, the full extended position H2 of the microneedle array holder 106 may never fully be reached when applied to the skin surface 50, because the skin surface 50 may immediately press back on the microneedle array holder 106 and cause the microneedle array holder 106 to move to its dampened position H3.
By way of example only, the first biasing element 111 and the second biasing element 113 are illustrated as being coil springs. As a result, the first biasing element 111 is illustrated as being compressed in
One embodiment of the arrangement of the actuator 104, the first biasing element 111, the microneedle array holder 106, and the second biasing element 113 is illustrated in
As described above, the plunger 130 and the microneedle array holder 106 can be coupled together, such that the microneedle array holder 106 can be moved with movement of the actuator 104. Specifically, in the illustrated embodiment, the recess 134 in the microneedle array holder 106 is dimensioned to receive the second end 133 of the plunger 130, e.g., in a snap-fit-type engagement. As shown in
As shown in
As further shown in
As a result of the above arrangement, the first biasing element 111 biases the actuator 104 upwardly (e.g., away from the skin surface 50), and the second biasing element 113 biases the microneedle array holder 106 downwardly (e.g., toward the skin surface 50), such that the first and second biasing elements 111 and 113 function to bias elements of the applicator 100 in opposite directions. Said another way, with reference to
One example of a counter assembly will now be described with reference to
The coupler 184 serves as a means for coupling the counter assembly 110 (and the other components that forms the actuator 104) to the button(s) 132 on the exterior of the housing 102. As shown in
The coupler 184 includes a first closed end 190, and a second open end 191. The guide 186 includes a first open end 192, and a second open end 193. The guide 186 also includes a flange 194, which by way of example is illustrated as being adjacent the second end 193 of the guide 186. The flange 194 can be dimensioned to be received within a channel 161 formed in the inner surface 140 of the housing 102 (see
As a result of the above exemplary coupling and arrangement of elements, as the button 132 and the coupler 184 are slid relative to the housing 102, the first closed end 190 of the coupler 184 abuts the first portion 187 of the counter 188, and the coupler 184 causes the first portion 187 and the second portion 189 of the counter 188 to be slid in the guide 186, as well as causing the plunger 130 to move, which in turn, moves the microneedle array holder 106, as described above, e.g., against the bias of the first biasing element 111.
The counter 188 (i.e., the first portion 187 and the second portion 189 thereof) can be slidably movable, or translationally movable (e.g., along the longitudinal axis A) relative to the guide 186 and the housing 102. As illustrated in
As shown in
As shown in
Operation of the counter assembly 110 will now be described with reference to
As shown in
As shown in
The illustrated embodiment includes discrete movement of the counter 188, such that the portion of the counter 188 that is rotatable (i.e., the second portion 189) is discretely rotatable relative to the housing 102, the longitudinal axis A, and the other elements described above. This discrete movement is due at least in part to the discrete channels 149 in the guide 186 into which the discrete projection(s) 160 can be moved, e.g., sequentially. While continuous or semi-continuous mechanisms can be employed, the discrete motion mechanism of the illustrated embodiment provides a simple, robust, precise and clear count that is not dependent on user variability. In addition, in some embodiments, such as in the illustrated embodiment, based on the construction of the counter assembly 110, the count may not be incremented until the actuator 104 has been fully moved to the second position P2, or until the microneedle array holder 106 has been fully moved to the extended position H2. This can be useful in maintaining an accurate count of the number of times a microneedle array 107 has been used, because it does not increment until the microneedle array 107 has been moved sufficiently to contact the skin 50.
Other suitable counting mechanisms can be employed, and the above-described arrangement and interaction of elements is described and illustrated by way of example only. Particularly utility, however, can be found in counter assemblies, such as the counter assembly 110 of the illustrated embodiment, that are mechanically coupled to, and movable with, other elements of the applicator 100. As such, the applicators of the present disclosure can robustly keep track of the number of times a microneedle array 107 has been used without relying on expensive electronic systems. After the maximum number of applications has been achieved for a given microneedle array 107, the microneedle array 107 can be decoupled from the microneedle array holder 106 (e.g., via the ejector 117, e.g., after moving the cover 122 to its second position C2), and a new microneedle array 107 can be loaded into the applicator 100.
The first biasing element 111 can have multiple functions in the applicator 100. For example, the first biasing element 111 can control the movement of the actuator 104 between its first and second positions P1 and P2 (i.e., by returning the actuator 104 to the first position P1 after a user has moved it to the second position P2). In turn, this action also controls the movement of the microneedle array holder 106 between its retracted and extended positions H1 and H2. As a result, the first biasing element 111 can control loading a microneedle array 107 into the applicator 100, as well as application of the microneedle array 107 onto the skin 50 after the microneedle array 107 has been loaded. In addition, the first biasing element 111 can drive and/or control the operation of the counter assembly 110 for counting the number of uses or applications for a given microneedle array 107.
As mentioned above, in some embodiments, active ingredients or agents (e.g., drugs) can be delivered via the microneedles 108 (e.g., via solid microneedles, as described below). Examples of pharmaceutically active agents (also referred to as “drugs”) that can be incorporated into the applicators of the present disclosure are those capable of local or systemic effect when administered to the skin. Some examples include buprenorphine, clonidine, diclofenac, estradiol, granisetron, isosorbide dinitrate, levonorgestrel, lidocaine, methylphenidate, nicotine, nitroglycerine, oxybutynin, rivastigmine, rotigotine, scopolamine, selegiline, testosterone, tulobuterol, and fentanyl, which are commercially available in the form of transdermal devices. Other examples include antiinflammatory drugs, both steroidal (e.g., hydrocortisone, prednisolone, triamcinolone) and nonsteroidal (e.g., naproxen, piroxicam); bacteriostatic agents (e.g., chlorhexidine, hexylresorcinol); antibacterials (e.g., penicillins such as penicillin V, cephalosporins such as cephalexin, erythromycin, tetracycline, gentamycin, sulfathiazole, nitrofurantoin, and quinolones such as norfloxacin, flumequine, and ibafloxacin); antiprotazoals (e.g., metronidazole); antifungals (e.g., nystatin); coronary vasodilators; calcium channel blockers (e.g., nifedipine, diltiazem); bronchodilators (e.g., theophylline, pirbuterol, salmeterol, isoproterenol); enzyme inhibitors such as collagenase inhibitors, protease inhibitors, acetylcholinesterase inhibitors (e.g., donepezil), elastase inhibitors, lipoxygenase inhibitors (e.g., A64077), and angiotensin converting enzyme inhibitors (e.g., captopril, lisinopril); other antihypertensives (e.g., propranolol); leukotriene antagonists (e.g., ICI204,219); anti-ulceratives such as H2 antagonists; steroidal hormones (e.g., progesterone); antivirals and/or immunomodulators (e.g., 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine, 1-(2-hydroxy-2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine, N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide, and acyclovir); local anesthetics (e.g., benzocaine, propofol, tetracaine, prilocaine); cardiotonics (e.g., digitalis, digoxin); antitussives (e.g., codeine, dextromethorphan); antihistamines (e.g., diphenhydramine, chlorpheniramine, terfenadine); narcotic analgesics (e.g., morphine, fentanyl citrate, sufentanil, hydromorphone hydrochloride); peptide hormones (e.g., human or animal growth hormones, LHRH, parathyroid hormones); cardioactive products such as atriopeptides; antidiabetic agents (e.g., insulin, exanatide); enzymes (e.g., anti-plaque enzymes, lysozyme, dextranase); antinauseants; anticonvulsants (e.g., carbamazine); immunosuppressives (e.g., cyclosporine); psychotherapeutics (e.g., diazepam); sedatives (e.g., phenobarbital); anticoagulants (e.g., heparin, enoxaparin sodium); analgesics (e.g., acetaminophen); antimigraine agents (e.g., ergotamine, melatonin, sumatriptan, zolmitriptan); antiarrhythmic agents (e.g., flecainide); antiemetics (e.g., metaclopromide, ondansetron, granisetron hydrochloride); anticancer agents (e.g., methotrexate); neurologic agents such as anxiolytic drugs; hemostatics; anti-obesity agents; dopamine agonists (e.g., apomorphine); GnRH agonists (e.g., leuprolide, goserelin, nafarelin); fertility hormones (e.g., hCG, hMG, urofollitropin); interferons (e.g., interferon-alpha, interferon-beta, interferon-gamma, pegylated interferon-alpha); and the like, as well as pharmaceutically acceptable salts and esters thereof. The amount of drug that constitutes a therapeutically effective amount can be readily determined by those skilled in the art with due consideration of the particular drug, the particular carrier, and the desired therapeutic effect.
In some embodiments, peptide therapeutic agents (natural, synthetic, or recombinant) can be delivered via the microneedles 108 (e.g., via solid microneedles). Examples of peptide therapeutic agents that can be incorporated into the applicators of the present disclosure include parathyroid hormone (PTH), parathyroid hormone related protein (PTHrP), calcitonin, lysozyme, insulin, insulinotropic analogs, glatiramer acetate, goserelin acetate, somatostatin, octreotide, leuprolide, vasopressin, desmopressin, thymosin alpha-1, atrial natriuretic peptide (ANP), endorphin, vascular endothelial growth factor (VEGF), fibroblast-growth factor (FGF), erythropoietin (EPO), bone morphogenetic proteins (BMPs), epidermal growth factor (EFG), granulocyte colony-stimulating factor (G-CSF), granulocyte macrophage colony stimulating factor (GM-CSF), insulin-like growth factor (IGF), platelet-derived growth factor (PDGF), growth hormone release hormone (GHRH), dornase alfa, tissue plasminogen activator (tPA), urokinase, ANP clearance inhibitors, lutenizing hormone releasing hormone (LHRH), melanocyte stimulating hormones (alpha & beta MSH), pituitary hormones (hGH), adrenocorticotropic hormone (ACTH), human chorionic gonadotropin (hCG), streptokinase, interleukins (e.g. IL-2, IL-4, IL-10, IL-12, IL-15, IL-18), protein C, protein S, angiotensin, angiogenin, endothelins, pentigetide, brain natriuretic peptide (BNP), neuropeptide Y, islet amyloid polypeptide (IAPP), vasoactive intestinal peptide (VIP), hirudin, glucagon, oxytocin, and derivatives of any of the foregoing peptide therapeutic agents.
In some embodiments, drugs that are of a large molecular weight may be delivered transdermally. Increasing molecular weight of a drug typically can cause a decrease in unassisted transdermal delivery. Examples of such large molecules include proteins, peptides, nucleotide sequences, monoclonal antibodies, vaccines, polysaccharides, such as heparin, and antibiotics, such as ceftriaxone. Examples of suitable vaccines include therapeutic cancer vaccines, anthrax vaccine, flu vaccine, Lyme disease vaccine, rabies vaccine, measles vaccine, mumps vaccine, chicken pox vaccine, small pox vaccine, hepatitis vaccine, hepatitis A vaccine, hepatitis B vaccine, hepatitis C vaccine, pertussis vaccine, rubella vaccine, diphtheria vaccine, encephalitis vaccine, Japanese encephalitis vaccine, respiratory syncytial virus vaccine, yellow fever vaccine, recombinant protein vaccine, DNA vaccines, polio vaccine, therapeutic cancer vaccine, herpes vaccine, human papilloma virus vaccine, pneumococcal vaccine, meningitis vaccine, whooping cough vaccine, tetanus vaccine, typhoid fever vaccine, cholera vaccine, tuberculosis vaccine, severe acute respiratory syndrome (SARS) vaccine, HSV-1 vaccine, HSV-2 vaccine, HIV vaccine and combinations thereof. The term “vaccine” thus includes, without limitation, antigens in the forms of proteins, polysaccharides, oligosaccharides, or weakened or killed viruses. Additional examples of suitable vaccines and vaccine adjuvants are described in U.S. Publication No. 2004/0049150 (Dalton et al.), the disclosure of which is hereby incorporated by reference.
In another embodiment, small-molecule drugs that are otherwise difficult or impossible to deliver by passive transdermal delivery may be used. Examples of such molecules include salt forms; ionic molecules, such as bisphosphonates, including sodium alendronate or pamedronate; and molecules with physicochemical properties that are not conducive to passive transdermal delivery.
In some embodiments, the microneedles 108 can be solid. In such embodiments, if an active agent is to be delivered to the skin, the active agent can be applied to the microneedles 108 by a variety of techniques, including, but not limited to painting (e.g., brushing), coating, dipping, or the like, or combinations thereof.
Microneedle arrays useful for practicing the present disclosure can have a variety of configurations and features, such as those described in the following patents and patent applications, the disclosures of which are incorporated herein by reference. One embodiment for the microneedle arrays 107 includes the structures disclosed in U.S. Patent Application Publication No. 2005/0261631 (Clarke et al.), which describes microneedles having a truncated tapered shape and a controlled aspect ratio. Another embodiment for the microneedle arrays 107 includes the structures disclosed in U.S. Pat. No. 6,091,975 (Daddona et al.), which describes blade-like microprotrusions for piercing the skin. Still another embodiment for the microneedle arrays 107 includes the structures disclosed in U.S. Pat. No. 6,312,612 (Sherman et al.), which describes tapered structures having a hollow central channel. Yet still another embodiment for the microneedle arrays 107 includes the structures disclosed in U.S. Pat. No. 6,379,324 (Garstein et al.), which describes hollow microneedles having at least one longitudinal blade at the top surface of the tip of the microneedle. A further embodiment for the microneedle arrays 107 includes the structures disclosed in U.S. Patent Application Publication Nos. US2012/0123387 (Gonzalez et al.) and US2011/0213335 (Burton et al.), which both describe hollow microneedles. A still further embodiment for the microneedle arrays 107 includes the structures disclosed in U.S. Pat. No. 6,558,361 (Yeshurun) and U.S. Pat. No. 7,648,484 (Yeshurun et al.), which both describe hollow microneedle arrays and methods of manufacturing thereof.
Various embodiments of microneedles that can be employed in the microneedle arrays of the present disclosure are described in PCT Publication No. WO 2012/074576 (Duan et al.), which describes liquid crystalline polymer (LCP) microneedles; and PCT Publication No. WO 2012/122162 (Zhang et al.), which describes a variety of different types and compositions of microneedles that can be employed in the microneedles of the present disclosure.
In some embodiments, the microneedle material can be (or include) silicon, glass, or a metal such as stainless steel, titanium, or nickel titanium alloy. In some embodiments, the microneedle material can be (or include) a polymeric material, preferably a medical grade polymeric material. Exemplary types of medical grade polymeric materials include polycarbonate, liquid crystalline polymer (LCP), polyether ether ketone (PEEK), cyclic olefin copolymer (COC), polybutylene terephthalate (PBT). Preferred types of medical grade polymeric materials include polycarbonate and LCP.
In some embodiments, the microneedle material can be (or include) a biodegradable polymeric material, preferably a medical grade biodegradable polymeric material. Exemplary types of medical grade biodegradable materials include polylactic acid (PLA), polyglycolic acid (PGA), PGA and PLA copolymer, polyester-amide polymer (PEA).
A microneedle or the plurality of microneedles in a microneedle array useful for practicing the present disclosure can have a variety of shapes that are capable of piercing the stratum corneum. In some embodiments, one or more of the plurality of microneedles can have a square pyramidal shape, triangular pyramidal shape, stepped pyramidal shape, conical shape, microblade shape, or the shape of a hypodermic needle. In some embodiments, one or more of the plurality of microneedles can have a square pyramidal shape. In some embodiments, one or more of the plurality of microneedles can have a triangular pyramidal shape. In some embodiments, one or more of the plurality of microneedles can have a stepped pyramidal shape. In some embodiments, one or more of the plurality of microneedles can have a conical shape. In some embodiments, one or more of the plurality of microneedles can have a microblade shape. In some embodiments, one or more of the plurality of microneedles can have the shape of a hypodermic needle. The shape can be symmetric or asymmetric. The shape can be truncated (for example, the plurality of microneedles can have a truncated pyramid shape or truncated cone shape). In a preferred embodiment, the plurality of microneedles in a microneedle array each have a square pyramidal shape.
In some embodiments, the plurality of microneedles in a microneedle array are solid microneedles (that is, the microneedles are solid throughout). In some embodiments, the plurality of solid microneedles in a solid microneedle array can have a square pyramidal shape, triangular pyramidal shape, stepped pyramidal shape, conical shape, or microblade shape. In a preferred embodiment, the plurality of solid microneedles in a solid microneedle array each have a square pyramidal shape.
In some embodiments, the plurality of microneedles in a microneedle array are hollow microneedles (that is, the microneedles contain a hollow bore through the microneedle). The hollow bore can be from the base of the microneedle to the tip of the microneedle or the bore can be from the base of the microneedle to a position offset from the tip of the microneedle. In some embodiments, one or more of the plurality of hollow microneedles in a hollow microneedle array can have a conical shape, cylindrical shape, square pyramidal shape, triangular pyramidal shape, or the shape of a hypodermic needle.
In some embodiments, one or more of the plurality of hollow microneedles in a hollow microneedle array can have a conical shape. In some embodiments, one or more of the plurality of hollow microneedles in a hollow microneedle array can have a cylindrical shape. In some embodiments, one or more of the plurality of hollow microneedles in a hollow microneedle array can have a square pyramidal shape. In some embodiments, one or more of the plurality of hollow microneedles in a hollow microneedle array can have a triangular pyramidal shape. In some embodiments, one or more of the plurality of hollow microneedles in a hollow microneedle array can have the shape of a hypodermic needle. In a preferred embodiment, the plurality of hollow microneedles in a hollow microneedle array each have the shape of a conventional hypodermic needle.
In some embodiments, each of the plurality of microneedles (or the average of all of the plurality of microneedles) has a height of about 200 to about 1200 micrometers, about 200 to about 1000 micrometers, about 200 to about 750 micrometers, or about 200 to about 600 micrometers.
In some embodiments, each of the plurality of microneedles (or the average of all of the plurality of microneedles) has a height of about 250 to about 1500 micrometers, about 500 to about 1000 micrometers, or about 500 to about 750 micrometers.
In some embodiments, each of the plurality of microneedles (or the average of all of the plurality of microneedles) has a height of about 800 to about 1400 micrometers.
In some embodiments, each of the plurality of microneedles (or the average of all of the plurality of microneedles) has a height of about 500.
In some embodiments, each of the plurality of microneedles (or the average of all of the plurality of microneedles) has a height of less than about 3000 micrometers. In other embodiments, each of the plurality of microneedles (or the average of all of the plurality of microneedles) has a height of less than about 1500 micrometers. In still other embodiments, each of the plurality of microneedles (or the average of all of the plurality of microneedles) has a height of less than about 1200 micrometers. In yet still other embodiments, each of the plurality of microneedles (or the average of all of the plurality of microneedles) has a height of less than about 1000 micrometers. In further embodiments, each of the plurality of microneedles (or the average of all of the plurality of microneedles) has a height of less than about 750 micrometers. In still further embodiments, each of the plurality of microneedles (or the average of all of the plurality of microneedles) has a height of less than about 600 micrometers.
In some embodiments, each of the plurality of microneedles (or the average of all of the plurality of microneedles) has a height of at least about 100 micrometers. In other embodiments, each of the plurality of microneedles (or the average of all of the plurality of microneedles) has a height of at least about 200 micrometers. In still other embodiments, each of the plurality of microneedles (or the average of all of the plurality of microneedles) has a height of at least about 250 micrometers. In further embodiments, each of the plurality of microneedles (or the average of all of the plurality of microneedles) has a height of at least about 500 micrometers. In still further embodiments, each of the plurality of microneedles (or the average of all of the plurality of microneedles) has a height of at least about 800 micrometers.
A single microneedle or the plurality of microneedles in a microneedle array can also be characterized by their aspect ratio. The aspect ratio of a microneedle is the ratio of the height of the microneedle, h to the width (at the base of the microneedle), w (as shown in
In some embodiments, the array of microneedles contains about 100 to about 1500 microneedles per cm2 of the array of microneedles.
In some embodiments, the array of microneedles contains about 200 to about 500 microneedles per cm2 of the array of microneedles.
In some embodiments, the array of microneedles contains about 300 to about 400 microneedles per cm2 of the array of microneedles.
In some embodiments, the array of microneedles contains about 3 to about 30 microneedles per cm2 of the array of microneedles.
In some embodiments, the array of microneedles contains about 3 to about 20 microneedles per cm2 of the array of microneedles.
In some embodiments, the array of microneedles contains about 10 to about 20 microneedles per cm2 of the array of microneedles.
In some embodiments, each of the plurality of microneedles (or the average of all of the plurality of microneedles) in a microneedle array can penetrate into the skin to a depth of about 50 to about 1500 micrometers, about 50 to about 400 micrometers, or about 50 to about 250 micrometers.
In some embodiments, each of the plurality of microneedles (or the average of all of the plurality of microneedles) in a microneedle array can penetrate into the skin to a depth of about 100 to about 400 micrometers, or about 100 to about 300 micrometers.
In some embodiments, each of the plurality of microneedles (or the average of all of the plurality of microneedles) in a microneedle array can penetrate into the skin to a depth of about 150 to about 1500 micrometers, or about 800 to about 1500 micrometers.
In some embodiments, each of the plurality of microneedles (or the average of all of the plurality of microneedles) in a microneedle array can penetrate into the skin to a depth of about 400 to about 800 micrometers.
The microneedles 108 can be arranged in any desired pattern or distributed over the microneedle substrate 109 randomly. As shown in
In some embodiments, the surface area of the substrate 109 covered with microneedles 108 is about 0.1 cm2 to about 20 cm2. In some of these embodiments, the surface area of the substrate 109 covered with microneedles 108 is about 0.5 cm2 to about 5 cm2. In some other of these embodiments, the surface area of the substrate 109 covered with microneedles 108 is about 1 cm2 to about 3 cm2. In still other of these embodiments, the surface area of the substrate 109 covered with microneedles 108 is about 1 cm2 to about 2 cm2.
In some embodiments, the microneedles of the present disclosure can be disposed over substantially the entire surface of the array. In other embodiments (e.g., as shown in
In some embodiments of microneedle arrays, the average spacing between adjacent microneedles (as measured from microneedle tip to microneedle tip) is between about 200 micrometers and about 2000 micrometers. In other embodiments of microneedle arrays, the average spacing between adjacent microneedles is between about 200 micrometers and about 600 micrometers. In still other embodiments of microneedle arrays, the average spacing between adjacent microneedles is between about 200 micrometers and about 300 micrometers. In yet still other embodiments of microneedle arrays, the average spacing between adjacent microneedles is between about 500 micrometers and about 600 micrometers.
In some embodiments of microneedle arrays, the average spacing between adjacent microneedles (as measured from microneedle tip to microneedle tip) is greater than about 200 micrometers. In other embodiments of microneedle arrays, the average spacing between adjacent microneedles is greater than about 500 micrometers.
In some embodiments of microneedle arrays, the average spacing between adjacent microneedles is less than about 2000 micrometers. In other embodiments of microneedle arrays, the average spacing between adjacent microneedles is less than about 1000 micrometers. In still other embodiments of microneedle arrays, the average spacing between adjacent microneedles is less than about 600 micrometers. In yet still other embodiments of microneedle arrays, the average spacing between adjacent microneedles is less than about 300 micrometers.
The microneedle arrays can be manufactured in any suitable way such as by injection molding, compression molding, metal injection molding, stamping, photolithography, or extrusion.
The following embodiments are intended to be illustrative of the present disclosure and not limiting.
1. A microneedle applicator comprising:
2. The microneedle applicator of embodiment 1, wherein a microneedle array is coupled to the microneedle array holder, and wherein the counter assembly is configured to count a number of times the microneedle array contacts a skin surface.
3. The microneedle applicator of embodiment 1 or 2, wherein the actuator is movable against a bias of the first biasing element to move from the first position to the second position to move the microneedle array holder from the retracted position to the extended position.
4. The microneedle applicator of any of embodiments 1-3, wherein the counter assembly is mechanically coupled to the actuator and the first biasing element.
5. The microneedle applicator of any of embodiments 1-4, wherein the counter mechanism is driven by the actuator and the first biasing element.
6. The microneedle applicator of any of embodiments 1-5, wherein the actuator is movable between the first position and the second position to cause the counter assembly to increment a count.
7. The microneedle applicator of any of embodiments 1-6, wherein the counter assembly includes a counter, and wherein the counter includes a display configured to display a count representative of a number of times the microneedle array holder is moved to the extended position.
8. The microneedle applicator of embodiment 7, wherein at least a portion of the counter is rotatably movable relative to the housing.
9. The microneedle applicator of embodiment 7 or 8, wherein the housing includes a longitudinal axis, and wherein at least a portion of the counter is rotatably movable relative to the longitudinal axis.
10. The microneedle applicator of embodiment 9, wherein the counter is discretely rotatable relative to the longitudinal axis of the housing.
11. The microneedle applicator of any of embodiments 7-10, wherein the housing includes an opening configured to display the count, and wherein at least a portion of the counter is rotatably movable relative to the opening in the housing.
12. The microneedle applicator of any of embodiments 7-11, wherein the counter assembly further includes a guide, wherein at least a portion of the counter is rotatably and slidably movable relative to the guide.
13. The microneedle applicator of embodiment 12, wherein the counter includes a first cam surface and the guide includes a second cam surface, and wherein the first cam surface and the second cam surface are configured to cam along one another to cause at least a portion of the counter to rotate relative to the guide.
14. The microneedle applicator of embodiment 12 or 13, wherein the guide is fixed relative to the housing.
15. The microneedle applicator of any of embodiments 12-14, wherein the counter includes a first portion and a second portion, wherein the first portion and the second portion of the counter are each slidably movable relative to the guide, wherein the second portion of the counter includes the display, and wherein the second portion is further rotatably movable relative to the guide.
16. The microneedle applicator of embodiment 15, wherein the second portion of the counter is further rotatably movable relative to the first portion of the counter.
17. The microneedle applicator of embodiment 15 or 16, wherein the guide includes a plurality of channels, and wherein at least one of the first portion and the second portion of the counter include at least one projection, each projection dimensioned to be received in one of the plurality of channels.
18. The microneedle applicator of embodiment 17, wherein the plurality of channels and the at least one projection allow the counter to be slid relative to the guide.
19. The microneedle applicator of any of embodiments 15-18, wherein the first portion of the counter includes a plurality of first engagement features, and wherein the second portion of the counter includes a plurality of second engagement features configured to engage the plurality of first engagement features.
20. The microneedle applicator of embodiment 19, wherein the plurality of second engagement features include a first cam surface, wherein the guide includes a second cam surface, and wherein the first cam surface and the second cam surface are configured to cam along one another to cause the second portion of the counter to rotate relative to the guide.
21. The microneedle applicator of any of embodiments 1-20, wherein the counter assembly includes a first cam surface and a second cam surface configured to cam along one another to cause at least a portion of the counter assembly to rotate to increment a count.
22. The microneedle applicator of any of embodiments 1-21, wherein the microneedle array holder is movable along an actuation axis between its retracted position and its extended position, wherein the housing includes a cover, and wherein the cover provides the base of the housing and the opening formed in the base, wherein the cover is movable between
23. The microneedle applicator of embodiment 22, wherein, when the cover is in its second position, the microneedle array holder is movable to the extended position to load a microneedle array.
24. The microneedle applicator of embodiment 22 or 23, wherein the microneedle array holder is recessed within the microneedle applicator when the cover is in the first position, and wherein the microneedle array holder is exposed when the cover is in the second position.
25. The microneedle applicator of any of embodiments 1-24, further comprising a second biasing element configured to bias the microneedle array holder in the extended position, wherein the microneedle array holder is movable against the bias of the second biasing element, when a threshold application force is applied, to move the microneedle array holder from the extended position to a dampened position.
1. A microneedle applicator comprising:
2. The microneedle applicator of embodiment 1, wherein the microneedle array holder has a first side configured to be coupled to the microneedle array and configured to be positioned toward the skin surface, and wherein the microneedle array holder is movable against the bias of the second biasing element when a threshold application force is applied to the first side of the microneedle array holder.
3. The microneedle applicator of embodiment 1 or 2, wherein the base of the housing is in contact with the skin surface when the microneedle array holder is in the extended position and the dampened position.
4. The microneedle applicator of any of embodiments 1-3, wherein when the microneedle array holder is in the dampened position, at least a portion of the microneedle array is positioned to contact the skin surface when the base of the housing is positioned on the skin surface.
5. The microneedle applicator of any of embodiments 1-4, wherein the actuator is movable against a bias of the first biasing element to move from the first position to the second position to move the microneedle array holder from the retracted position to the extended position.
6. The microneedle applicator of any of embodiments 1-5, wherein the first biasing element is a spring.
7. The microneedle applicator of any of embodiments 1-6, wherein the first biasing element is compressed when the actuator is in the second position.
8. The microneedle applicator of any of embodiments 1-7, wherein the second biasing element is a spring.
9. The microneedle applicator of any of embodiments 1-8, wherein the second biasing element is compressed when the microneedle array holder is in the dampened position.
10. The microneedle applicator of any of embodiments 1-9, wherein the second biasing element is compressed between the microneedle array holder and the actuator when the microneedle array holder is in the dampened position.
11. The microneedle applicator of any of embodiments 1-10, wherein the first biasing element biases the actuator upwardly relative to the skin surface, and wherein the second biasing element biases the microneedle array holder downwardly relative to the skin surface.
12. The microneedle applicator of any of embodiments 1-11, wherein the actuator is movable from the first position to the second position in a first direction, wherein the microneedle array holder is movable from the extended position to the dampened position in a second direction, and wherein the first direction is different from the second direction.
13. The microneedle applicator of embodiment 12, wherein the first direction and the second direction are opposite one another.
14. The microneedle applicator of any of embodiments 1-13, wherein the microneedle array holder is movable between the extended position and the dampened position when the actuator is maintained in the second position.
15. The microneedle applicator of any of embodiments 1-14, wherein the actuator includes a plunger, and wherein the first biasing element is compressed between the plunger and a wall of the housing when the plunger is in the second position.
16. The microneedle applicator of any of embodiments 1-15, wherein the actuator includes a plunger, and wherein the second biasing element is compressed between the microneedle array holder and the plunger when the microneedle array holder is in the dampened position.
17. The microneedle applicator of any of embodiments 1-16, wherein the actuator includes a plunger, and wherein at least a portion of the plunger is configured to be coupled to the microneedle array holder.
18. The microneedle applicator of any of embodiments 1-17, wherein the microneedle array holder is movable along an actuation axis between its retracted position and its extended position, wherein the housing includes a cover, and wherein the cover provides the base of the housing and the opening formed in the base, wherein the cover is movable between
19. The microneedle applicator of embodiment 18, wherein, when the cover is in its second position, the microneedle array holder is movable to the extended position to load a microneedle array.
20. The microneedle applicator of embodiment 18 or 19, wherein the microneedle array holder is recessed within the microneedle applicator when the cover is in the first position, and wherein the microneedle array holder is exposed when the cover is in the second position.
21. The microneedle applicator of any of embodiments 1-20, further comprising a counter assembly configured to count a number of times the microneedle array holder is moved between the retracted position and the extended position.
1. A microneedle applicator comprising:
2. The microneedle applicator of embodiment 1, wherein the cover is removable from the housing.
3. The microneedle applicator of embodiment 1 or 2, wherein the cover is removable from the housing when the cover is in the first position and when the cover is in the second position.
4. The microneedle applicator of any of embodiments 1-3, wherein the cover is decoupled from the housing when the cover is in the second position.
5. The microneedle applicator of any of embodiments 1-4, wherein the housing is elongated along a longitudinal axis, and wherein the actuation axis is parallel to the longitudinal axis of the housing.
6. The microneedle applicator of embodiment 5, wherein the longitudinal axis of the housing passes through the opening in the base of the cover when the cover is in the first position.
7. The microneedle applicator of any of embodiments 1-6, wherein the microneedle array holder is recessed within the microneedle applicator when the cover is in the first position, and wherein the microneedle array holder is exposed when the cover is in the second position.
8. The microneedle applicator of any of embodiments 1-7, wherein the microneedle array holder is recessed within a cavity defined by the housing and the cover when the cover is in the first position, and wherein the microneedle array holder is exposed when the cover is in the second position.
9. The microneedle applicator of any of embodiments 1-8, wherein the cover is coupled to the housing when the cover is in the first position and the second position.
10. The microneedle applicator of any of embodiments 1-9, wherein the housing includes a base, and wherein the cover is coupled to and covers the base of the housing when the cover is in the first position, but wherein the base of the housing is exposed when the cover is in the second position.
11. The microneedle applicator of embodiment 10, wherein at least a portion of the microneedle array holder extends beyond the base of the housing when the microneedle array holder is in its extended position.
12. The microneedle applicator of embodiment 10 or 11, wherein the base of the housing includes an opening formed therein, and wherein the microneedle array holder is movable through the opening formed in the base of the housing when the microneedle array holder moves between its retracted position and its extended position.
13. The microneedle applicator of any of embodiments 10-12, wherein the housing includes a cavity that extends through the base to define an opening in the base, and wherein the microneedle array holder is at least partially located in the cavity of the housing when the microneedle array holder is in its retracted position, and wherein the microneedle array holder extends through the opening and beyond the base of the housing when the microneedle array holder is in its extended position.
14. The microneedle applicator of any of embodiments 1-13, wherein the cover includes a plurality of second positions, and wherein the cover is movable between the first position and any of the plurality of second positions.
15. The microneedle applicator of any of embodiments 1-14, wherein the cover is pivotally movable with respect to the housing.
16. The microneedle applicator of any of embodiments 1-15, wherein the cover is slidably movable with respect to the housing.
17. The microneedle applicator of any of embodiments 1-16, wherein the cover is pivotally and slidably movable with respect to the housing.
18. The microneedle applicator of any of embodiments 1-17, wherein the cover is configured to pivot about a rotational axis that is oriented substantially perpendicularly with respect to a longitudinal axis of the housing.
19. The microneedle applicator of any of embodiments 1-18, wherein the cover is configured to pivot about a rotational axis that is oriented substantially perpendicularly with respect to the actuation axis.
20. The microneedle applicator of any of embodiments 1-19, wherein the cover is configured to pivot about a rotational axis that is oriented substantially perpendicularly with respect to a direction that is normal to the skin surface.
21. The microneedle applicator of any of embodiments 1-20, wherein the cover is configured to pivot about a rotational axis that is oriented substantially parallel with respect to the skin surface.
22. The microneedle applicator of any of embodiments 1-21, wherein the cover and the housing are coupled together by a snap-fit-type engagement when the cover is in the first position.
23. The microneedle applicator of any of embodiments 1-22, wherein the second position is a discrete position defined by a detent.
24. The microneedle applicator of any of embodiments 1-23, wherein the cover is further movable between the first position, the second position, and a third position spaced a distance along the actuation axis from the first position.
25. The microneedle applicator of embodiment 24, wherein when the cover is in the first position, the microneedle applicator is in an assembled configuration, and wherein when the cover is in the third position, the microneedle applicator is in a disassembled configuration.
26. The microneedle applicator of embodiment 24 or 25, wherein the actuation axis passes through the opening in the base of the cover when the cover is in the third position.
27. The microneedle applicator of any of embodiments 24-26, wherein the third position is located intermediately of the first position and the second position, such that the cover moves through the third position when moved between the first position and the second position.
28. The microneedle applicator of any of embodiments 24-27, wherein the cover is coupled to the housing when the cover is in the first position, the second position, and the third position.
29. The microneedle applicator of any of embodiments 24-28, wherein the housing includes a base, and wherein the cover is coupled to and covers the base of the housing when the cover is in the first position, but wherein the base of the housing is exposed when the cover is in the second position and the third position.
30. The microneedle applicator of embodiment 29, wherein at least a portion of the microneedle array holder extends beyond the base of the housing when the microneedle array holder is in its extended position.
31. The microneedle applicator of embodiment 29 or 30, wherein the base of the housing includes an opening formed therein, and wherein the microneedle array is movable through the opening formed in the base of the housing when the microneedle array moves between its retracted position and its extended position.
32. The microneedle applicator of any of embodiments 24-31, wherein the cover is pivotally movable between the third position and the second position.
33. The microneedle applicator of any of embodiments 24-32, wherein the cover is slidably movable between the first position and the third position.
34. The microneedle applicator of any of embodiments 24-33, wherein the cover includes a plurality of second positions, and wherein the cover is movable between the third position and any of the plurality of second positions.
35. The microneedle applicator of any of embodiments 24-34, wherein the cover is free to pivot about an axis when the cover is in the third position.
36. The microneedle applicator of embodiment 35, wherein the cover is movable from the third position to the second position by pivoting about the axis.
37. The microneedle applicator of any of embodiments 24-36, wherein the second position is a discrete position defined by a detent.
38. The microneedle applicator of any of embodiments 24-37, wherein the cover is slidable along a longitudinal axis of the housing to move between the first position and the third position, and wherein the cover is rotatable about an axis that is oriented substantially perpendicularly with respect to the longitudinal axis of the housing to move between the third position and the second position.
39. The microneedle applicator of any of embodiments 1-38, wherein when the cover is in the first position and the microneedle array is coupled to the microneedle array holder, the microneedle array is movable between
40. The microneedle applicator of any of embodiments 1-39, wherein when the cover is in the second position, the microneedle array holder is movable between its retracted position and its extended position to couple a microneedle array to the microneedle array holder.
41. The microneedle applicator of any of embodiments 1-40, wherein the microneedle array holder is biased in its retracted position by a biasing element.
42. The microneedle applicator of any of embodiments 1-41, further comprising an actuator movable with respect to the housing between a first position and a second position to cause the microneedle array holder to move between the retracted position and the extended position.
43. The microneedle applicator of embodiment 42, further comprising a first biasing element configured to bias the actuator in the first position.
44. The microneedle application of embodiment 43, wherein the actuator is movable against a bias of the first biasing element to move from the first position to the second position to move the microneedle array holder from the retracted position to the extended position.
45. The microneedle application of embodiment 43 or 44, further comprising a second biasing element configured to bias the microneedle array holder in the extended position, wherein the microneedle array holder is movable against the bias of the second biasing element, when a threshold application force is applied, to move the microneedle array holder from the extended position to a dampened position.
46. The microneedle applicator of any of embodiments 1-45, further comprising a counter assembly configured to count a number of times the microneedle array holder is moved between the retracted position and the extended position.
47. The microneedle applicator of any of embodiments 1-43, wherein when the microneedle array holder is in the retracted position and the microneedle array is coupled to the microneedle array holder, the microneedle array is recessed within the housing such that the microneedle array does not contact the skin surface when the base of the cover is positioned in contact with the skin surface, and wherein when the microneedle array holder is in the extended position and the microneedle array is coupled to the microneedle array holder, at least a portion of the microneedle array is positioned to contact the skin surface when the base of the cover is in contact with the skin surface.
48. A kit comprising:
The embodiments described above and illustrated in the figures are presented by way of example only and are not intended as a limitation upon the concepts and principles of the present disclosure. As such, it will be appreciated by one having ordinary skill in the art that various changes in the elements and their configuration and arrangement are possible without departing from the spirit and scope of the present disclosure.
All references and publications cited herein are expressly incorporated herein by reference in their entirety into this disclosure.
Various features and aspects of the present disclosure are set forth in the following claims.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2014/031307 | 3/20/2014 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
61804399 | Mar 2013 | US | |
61804387 | Mar 2013 | US | |
61804396 | Mar 2013 | US |